CASE STUDY Production Chemicals and Services Uninterrupted supply to meet demand cGMP * Distribution Services Results Situation A large biopharmaceutical company faced added complexity and operational costs within its direct material supply chain operations, as a result of significantly increased campaign volumes at their U.S. manufacturing site. Management was concerned about the potential increased risk for production delays and as a result, was taking specific actions to mitigate this risk. This included increasing Full Time Equivalent (FTE) resources within supply chain and quality, as well as investing significant capital in raw material inventory. Additionally, they were concerned about the site’s warehouse capacity for direct raw materials – especially if the campaign volume

Join for free to read